From a shareholder point of view its a matter of what gives the...

From a shareholder point of view its a matter of what gives the best value in shareprice return, no toll treat = more dilution eg we could be pushing 200+mill shares by end of next year with no toll treat at say 150 mill with toll treat. The tighter the register the faster the moves higher.

$400mill market cap @200 mill shares is $2.00 per share
$400mill market cap @150 mill shares is $2.60 per share

and so on...IMO there is high grade all over the show so toll treating the first stage to avoid dilution gets my vote.

POG hammered overnight on the back of the Pfizer news, hopefully short lived as the MMT train gathers momentum in the US